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Introduction
Diabetes mellitus (DM) is characterized by abnormal glucose 
metabolism which is usually associated with elevated blood glu-
cose levels due to insulin deficiency or resistance, diminished glu-
cose utilization in tissues that require insulin for glucose uptake, 
tissues in which glucose transport is not regulated by insulin 
(cardiac tissue, blood vessels, peripheral nerves, renal medulla 
and ocular lens) face severe and sustained hyperglycemia.1 One 
of the major complications of diabetes is the progression of car-
diovascular disease in both the macro- and micro circulation. 
Microvascular  complications  of  diabetes  include  nephropathy 
and retinopathy, macrovascular complication results in athero-
sclerotic cardiovascular disease such as coronary artery disease, 
cerebrovascular  disease  and  peripheral  vascular  disease  which 
are the leading cause of death in diabetic population.2-4 Several 
studies had demonstrated that oxidative stress, mediated mainly 
by hyperglycemia-induced generation of free radicals, contrib-
utes to the development and progression of diabetes and related 
complications. Oxidative stress describes the condition where the 
amount of reactive oxygen species (ROS) overpowers the amount 
of  neutralizing  agents  or  antioxidants.5-7  Hyperglycemia  can 
induce oxidative stress through advanced glycation end product 
(AGEs) formation, increased flux through the polyol pathway, 
increased activation of protein kinase C (PKC) and increased flux 
through hexosamine pathway.8
Formation of excess superoxide by the mitochondrial trans-
port  chain  during  hyperglycemic  has  been  reported  as  the   
initial factor of diabetes induced oxidative stress.9 The formation 
of superoxide and the subsequent increase in oxidative stress may 
lead  to  endothelial  dysfunction  and  ultimately  cardiovascular 
disease (CVD) through several different mechanisms.10 AGEs 
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because there are no adequate data from large clinical trails are 
available.
Degenerative changes occur in heart, kidney, brain and other 
neural tissues during diabetes. These include cardiomyopathy, 
nephropathy  and  neuropathy  and  are  common  complications 
of diabetes mellitus. This pathogenicity is believed to be due to 
oxidative damage of the tissues by oxygen free radicals. Several 
reports are available about the changes in antioxidant enzymes 
levels  in  various  tissues  (liver,  kidney  and  heart)  of  diabetic 
rats.21  Several natural products such as Momordica charantia, 
Azadirachta  indica,  Gymnema  sylvestre,  Pterocarpus  marsupim, 
Coccinia indica, Trigonella foenum graecum, Allium sativum and 
Ocimum sanctum, etc. are being used in India as well as other 
parts of the world for the management of diabetes and to over-
come its complications. These plants are found to be effective 
and their low cost and minimal side effects have increased the 
interest of scientists to develop plant based drugs for manag-
ing diabetes. Momordica charantia (MC) and Trigonella foenum 
graecum (TFG) are reported to have beneficial effects in other 
disease conditions. MC leaf extracts have been reported to pos-
sess antibacterial activities against E. coli, Salmonella paratyphi, 
Shigella dysenterae and Streptomyces griseus. Fruit extracts of MC 
are reported to have beneficial effects against Helicobacter pylori 
infection and gastric ulcers.22,23 Inhibitory activity against the 
larvae of filarial vector, Culex quinquefasciatus has been found 
in the seed extracts of MC.24 The TFG seed paste (applied exter-
nally) is used to treat abscess, boils, ulcers and burns and con-
sumption of  TFG seed powder possess beneficial effects against 
gastritis and gastric ulcers due to bacterial infections.25,26 Several 
reports are available regarding the anti-hyperglycemic effects of 
MC and  TFG but the data about their antioxidant potential is 
scantly in heart tissue from diabetes. Therefore, present study has 
been planed on MC and TFG to evaluate their effects on cardiac 
antioxidant status in alloxan induced diabetic rats. 
Results
Effect on body weight and fasting blood glucose (FBG) levels. 
All the rats in all the six groups chosen in the present study were 
having almost same body weight. Rats in group I-III and V-VI 
showed almost similar growth during the period (30 days) of 
study as almost similar gain in weight was observed in these rats 
whereas rats in group IV (diabetic) showed a significant decrease 
in body weight, from 184±1.92 to 147±2.98 gram body weight 
in Table 1.
An intraperitonial dose (150 mg/kg body weight) of alloxan 
resulted in increase in fasting blood glucose level from 101.4±2.3 
mg/dl to 284±3.16 mg/dl after 96 hours of alloxan injection 
(group IV to VI), this high level of FBG was maintained in group 
IV (diabetic) throughout the period of study, treatment of dia-
betic rat with MC extract (group V) and TFG extract (group VI) 
showed a time dependent decrease in FBG levels. (Table 2) 
Levels of cardiac lipid peroxidation. The TBARS level were 
significantly increased (p < 0.001) in cardiac tissue of diabetic 
rats (group IV) by 2.66-fold when compared with normal rats 
(group I). However there was no significant change was observed 
can produce ROS, bind to receptors that promote oxidative stress 
and trigger mechanisms that generates intracellular oxidants.11 
An increased polyol pathway flux during hyperglycemia is due to 
increase in aldose reductase (AR) activity in cardiac tissues which 
reduces glucose to sorbitol by consuming NADPH. AR is also 
been reported to metabolize GSH-lipid derived aldehyde adducts 
which results in decrease in GSH and subsequently increases oxi-
dative stress.12,13
Because the production of ROS leads to endothelium dys-
function, a precursor to the development of CVD thus targeting 
ROS seems to be a logical approach to combat the vascular com-
plications of diabetes. Our body has variety of antioxidants to 
counteract the damaging effects of ROS. Enzymes such as super-
oxide dismutase (SOD) converts superoxide to hydrogen perox-
ide (H2O2) which is then transformed into water by catalase in 
lysosomes or by glutathione peroxidase (GPx) in mitochondria.14
The diabetes altered activities of these enzymes and reduced 
level  of  GSH  have  been  observed  which  affect  the  ability  to 
defend against oxidative stress.15 Non enzymatic antioxidant such 
as vitamin A, C and E are consumed in every day diet. Several 
animal and human studies were done using these non enzymatic 
antioxidant to combat endothelial dysfunction resulted from dia-
betes induced oxidative stress.16,17 Vitamin C and E have been 
given  particular  attention  because  of  their  known  superoxide 
scavenger property and they have been tested either alone or in 
combination.2 Not all studies yielded positive result, as some of 
the studies indicated that antioxidant vitamin supplementation 
may actually lead to endothelium dysfunction in both diabetic 
and normal animals.18,19 Long term nonenzymetic antioxidant 
therapy in humans has not been very successful. A combination 
of vitamin C and E was given to patients with both type 1 and 
type 2 diabetes showed that endothelium dysfunction improved 
only in patient with type 1 diabetes.20
Clinical trials of antioxidant therapy in diabetes especially in 
the form of supplemental vitamins have not shown decrease risk of 
cardiovascular outcomes. Therefore, supplementation with vita-
min  C,  E  and  other  antioxidant  such  as  tetrahydrobiopterin 
(BH4) and benfotiamine should be recommended with caution 
Table 1. Change in body weight in control and experimental groups of 
rats
Groups Body weight (grams)
(0 day) (30th day)
I (Normal control) 184.3 ± 3.77 201.4 ± 2.3
II (Normal + MC) 183 ± 1.58 197.4 ± 3.64
III (Normal + TFG) 188.6 ± 1.67 201.2 ± 2.77
IV (Diabetic control) 184.2 ± 1.92 147 ± 2.91*
V (Diabetic + MC) 184 ± 1.58 198.2 ± 1.92*
VI (Diabetic + TFG) 189.6 ± 1.14 199.6 ± 2.4*
each values is a mean ± sD (n = 5 in each group). *Values are statistically 
significant at p < 0.001.  Normal + MC treated (groups II), normal + TFG 
treated (group III) and diabetic control (group IV) were compared with 
normal control (group I). Diabetic + MC treated (group V) and diabetic 
+ TFG treated (groups VI) were compared with diabetic control (group 
IV). The experiments were repeated thrice. MC, Momordica charantia; 
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in normal rats treated with MC and TFG (group II and III). 
Treatment of diabetic rats with MC (group V) resulted in signifi-
cant decrease (p < 0.001) in TBARS level from 105 nM/g tissue 
(diabetic rats) to 60.00 nM/g tissue. Similarly, TFG treatment 
to the diabetic rats (group VI) resulted in significant decrease 
(p<0.001) in TBARS levels from 105.00 nM/g tissue (diabetic 
rats) to 45.96 nM/g tissue. (Table 3)
GSH Content. The GSH content were significantly decreased 
(p<0.001)  in  cardiac  tissue  of  diabetic  rats  (group  IV)  from 
0.86±0.25 to 0.49±0.02 µM/mg protein when compared with 
normal rats (group I). However there was no significant change 
was observed in normal rats treated with MC and TFG (group 
II  and  III).  Treatment  of  diabetic  rats  with  MC  (group  V) 
resulted in significant increase (p<0.001) in GSH content from 
0.49±0.02 µM/mg protein (diabetic rats) to 1.01±0.09 µM/mg 
protein. Similarly, TFG treatment to the diabetic rats (group VI) 
resulted in significant increase (p<0.001) in GSH contents from 
0.49±0.02 µM/mg protein (diabetic rats) to 1.1±0.12 µM/mg 
protein. (Table 3)
Activities of cardiac antioxidants enzymes. The activities of 
antioxidants (SOD, CAT and GST) were significantly decreased 
(p<0.001, p<0.001 and p<0.001) in cardiac tissue of diabetic rats 
(group IV) when compared with normal rats (group I). However 
there was no significant change was observed in normal rats treated 
with MC and TFG (group II and III). Treatment of diabetic rats 
with MC (group V) resulted in significant increase (p<0.001, 
p<0.001 and p<0.001) in antioxidants activities. Similarly, TFG 
treatment to the diabetic rats (group VI) resulted in significant 
increase (p<0.001, p<0.001 and p<0.001) in antioxidants activi-
ties when compared with diabetic rats (group IV) (Figs. 1–3).
Discussion
Cardiovascular disease is one of the major complications of diabe-
tes. Diabetes induced oxidative stress has been implicated in the 
progression of pathogenesis of the cardiovascular complications 
and antioxidants were considered as promising therapeutic strat-
egy.2 In spite of the presence of large number of antidibetic phar-
maceuticals agents, there is renewed interest in remedies from 
plants sources because of their lesser side effects and low cost. 
In the present study, anti-diabetic and antioxidant potentials of 
Table 2. Fasting blood glucose levels in control and experimental groups of rats
Groups Fasting blood glucose levels (mg/dl)
0 day 7th day 14th day 21st day 30th day
I (Normal control) 101.4 ± 2.3 103 ± 1.87 99.8 ± 1.3 103.4 ± 1.34 101 ± 1.58
II (Normal + MC) 102.4 ± 1.94 99.6 ± 2.07 98.6 ± 1.14 98 ± 1.58 95.2 ± 0.84
III (Normal + TFG) 103.8 ± 1.92 101.4 ± 2.07 96.4 ± 0.89 94.4 ± 1.51 90.8 ± 1.48
IV (Diabetic control) 284 ± 3.16* 282 ± 1.58* 280 ± 1.58* 276.2 ± 1.48* 275.8 ± 1.48*
V (Diabetic + MC) 281.4 ± 2.07 234.6 ± 1.67* 183.2 ± 1.64* 137.4 ± 2* 116.4 ± 1.81*
VI (Diabetic + TFG) 283.6 ± 2.3 229.6 ± 1.14* 159.8 ± 1.3* 127 ± 1.58* 103 ± 1.58*
each values is a mean ± sD (n = 5 in each group). *Values are statistically significant at p < 0.001.  Normal + MC treated (groups II), normal + TFG 
treated (group III) and diabetic control (group IV) were compared with normal control (group I). Diabetic + MC treated (group V) and diabetic + TFG 
treated (groups VI) were compared with diabetic control (group IV). The experiments were repeated thrice. MC, Momordica charantia; TFG, Trigonella 
foenum graecum.
Table 3. Levels of TBaRs and Gsh in control and experimental groups 
of rats
Groups TBARS GSH
(nmoles/g of  
tissue)
(µmoles/mg  
protein)
I (Normal control) 39.45 ± 1.89 0.86 ± 0.25
II (Normal + MC) 38.16 ± 1.17 0.94 ± 0.6
III (Normal + TFG) 37.9 ± 1.62 0.92 ± 0.1
IV (Diabetic con-
trol)
105.3 ± 12.22* 0.49 ± 0.02*
V (Diabetic + MC) 60.13 ± 2.84* 1.01 ± 0.09*
VI (Diabetic + TFG) 45.96 ± 4.0* 1.1 ± 0.12*
each values is a mean ± sD (n = 5 in each group). *Values are statistically 
significant at p < 0.001.  Normal + MC treated (groups II), normal + TFG 
treated (group III) and diabetic control (group IV) were compared with  
normal control (group I). Diabetic + MC treated (group V) and diabetic 
+ TFG treated (groups VI) were compared with diabetic control (group 
IV). The experiments were repeated thrice. MC, Momordica charantia; 
TFG, Trigonella foenum graecum; TBaRs, Thiobarbituric acid reactive 
substances; Gsh, Reduced glutathione.
aqueous extracts of Momordica charantia and Trigonella foenum 
graecum have been evaluated in heart tissue in alloxan induced 
diabetic rats.
A dose of alloxan 150 mg/kg body weight was chosen in this 
study as up to 140–200 mg/kg body weight alloxan doses were 
reported to non lethal. In this range of alloxan dose pancreatic 
β cells are so damaged that insulin is secreted but not in suf-
ficient amounts to regulate blood glucose levels, resulting in sig-
nificant increase in fasting blood glucose levels. The suggested 
mechanism of action of alloxan is generation of oxidative stress 
in pancreatic tissues.27 Treatment of diabetic rats with aqueous 
extracts of MC and TFG (13.33 g pulp/kg body weight/day and 
9 g paste/kg body weight/day) for 30 days after establishment 
of hyperglycemia resulted in significant reduction of FBG levels 
which might be due to enhanced peripheral glucose utilization or 
these plant extracts potentiate the insulin effect by rejuvenation 
of damaged pancreatic β cell.
Hypoinsulinemia due to alloxan induced diabetes leads to 
several  biochemical  alterations  including  lipid  peroxidation.28 
Increased plasma total lipid, triglycerides and total cholesterol www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  293
Figure 1. activity of superoxide dismutase (sOD) in control and ex-
perimental groups of rats. sOD activity was measured by the method of 
Misra and Fridovich.42 The activity was expressed in U/min/mg protein. 
One unit of enzyme activity has been defined to cause 50% inhibition 
of auto-oxidation of epinephrine by 1.0 ml of homogenate. each values 
is a mean ± SD (n = 5 in each group). *Values are statistically significant 
at p<0.001. Normal + MC treated (groups II), normal + TFG treated 
(group III) and diabetic control (group IV) were compared with normal 
control (group I). Diabetic + MC treated (group V) and diabetic + TFG 
treated (groups VI) were compared with diabetic control (group IV).
The experiments were repeated thrice. MC, Momordica charantia; TFG, 
Trigonella foenum graecum.
catacholamines are also increased in diabetics, compound the 
effect  by  stimulating  lipolysis.  Increased  lipid  peroxidation 
impairs membrane functions, its product ate harmful to most of 
the cells in the body and associated with a variety of diseases.29 
Our present study showed a significant (p < 0.001) increase in 
TBARS content in heart tissue of diabetic rats suggesting that 
peroxidative injury may be involved in diabetes related cardiac 
dysfunctions. The aqueous extract of MC and TFG could sig-
nificantly lower the elevated heart lipid peroxidation products 
levels (Table 3).  This indicates that aqueous extract of MC and 
TFG may contain potent inhibitory molecule (s) to protect heart 
tissue from oxidative damage. The significant improvement in 
serum lipid profile and lipid peroxide formation (in liver and kid-
ney) was observed when diabetic rats were treated with TFG and 
MC.30,31
Reduced glutathione (GSH) is known to protect the cellular 
system against the toxic effects of lipid peroxidation.32 GSH func-
tion as direct free radical scavenger, as a co-substrate for glutathi-
one peroxidase (GPx) activity and as a cofactor for many enzymes 
and forms conjugates in endo and xenobiotic reactions.33 Several 
studies support the hypothesis that prolonged hyperglycemia up 
regulate the polyol pathways as well as advanced glycation end 
products formation and free radical generation rates. A relative 
depletion of NADPH occurs due to AR activation in heart tissue 
of diabetic rats. Role of AR has also been implicated in detoxifi-
cations of lipid peroxidation products such as 4-hydroxynonenal 
(4-HNE) and malondialdehyde (MDA) in the form of GSH-
aldehyde adducts.12 All these may lead to depleted GSH levels 
in heart tissue. Our results also in accordance to these finding 
as decreased GSH levels were estimated in heart tissue because 
are common in diabetics. This may be due to increased activ-
ity of lipases (sensitive to insulin) which  results  in increased 
lipolysis. The levels of other hormones such as glucagon and 
Figure 2. activity of catalase in control and experimental groups of 
rats. Catalase activity was estimated by the method of sinha.41 The 
activity was expressed as μmoles h2O2 decomposed/min/mg protein. 
each values is a mean ± sD (n=5 in each group). *Values are statistically 
significant at p<0.001. Normal + MC treated (groups II), normal + TFG 
treated (group III) and diabetic control (group IV) were compared with 
normal control (group I). Diabetic + MC treated (group V) and diabetic 
+ TFG treated (groups VI) were compared with diabetic control (group 
IV).The experiments were repeated thrice. MC, Momordica charantia; 
TFG, Trigonella foenum graecum.
Figure 3. activity of glutathione s-tranferase (GsT) in control and 
experimental goups of rats. GsT activity was assayed as µmoles of 
Gsh-CDNB conjugate formed /min./mg protein according to the 
method of habig et al.43 One unit of GST activity is defined as the 
amount of enzyme catalyzing the formation of 1.0 µmole of product 
per min/mg protein under assay conditions. each values is a mean ± sD 
(n = 5 in each group). *Values are statistically significant at p < 0.001. 
Normal + MC treated (groups II), normal + TFG treated (group III) and 
diabetic control (group IV) were compared with normal control (group 
I). Diabetic + MC treated (group V) and diabetic + TFG treated (groups 
VI) were compared with diabetic control (group IV). The experiments 
were repeated thrice. MC, Momordica charantia; TFG,Trigonella foenum 
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were  provided  a  standard  pellet  diet  (Hindustan  Lever  Ltd, 
Mumbai, India) and had free access to water. Prior permission 
for animal use and approval of the protocol were obtained from 
the Institutional Animal Ethical Committee.
Induction  of  diabetes.  Diabetes  in  rats  was  induced  with 
a  single  injection  of  alloxan  monohydrate  (150  mg/kg  body 
weight), dissolved in sterile 0.15 M normal saline, by intraperito-
neal route.39 Blood samples to measure FBG were obtained by tail 
vain puncture of all groups of rats, glucose levels were determined 
on different days using a glucometer (One touch ultra blood glu-
cose monitoring system from Lifescan, Johonson and Johonson 
Company). After fifth day the development of diabetes was con-
firmed,  rats with FBG range 250–300 mg/dl were considered as 
diabetic rats and used for the further experiments. 
Treatment. Rats were divided into six groups.
  Group I  Normal control
  Group  II    Normal  +  MC  treated  (13.33  g  pulp/kg   
  body weight/day)
  Group III  Normal + TFG treated (9 g seed powder/kg  
  body weight/day)
  Group IV Diabetic control
  Group  V    Diabetic  +  MC  treated  (13.33  g  pulp/kg   
  body weight/day)
  Group VI Diabetic +TFG treated (9 g seed powder/kg  
  body weight/day)
The body weight was measured on the first (after the diabetes 
was confirmed) and 30th day of the experiment. The extracts 
were given orally by gastric intubation to the rats of respective 
groups (II, III, V and VI) once daily for 30 days. Control animals 
(groups I and IV) received the same amount of normal saline. 
After 30 days of treatment, rats were fasted overnight and   
sacrificed.  Heart  tissue  was  collected  separately  and  stored  at 
-20°C.
Chemicals. Alloxan monohydrate, 5,5’-Dithio-bis 2-nitroben-
zeoic acid (DTNB), Epinephrine, glacial metaphosphoric acid 
and Glutathione were purchased from Sigma chemical company 
Inc., St Louis, Mo, USA. All other chemicals used were of ana-
lytical  grade  and  obtained  from  SRL  (India),  Qualigens  fine 
chemicals (India).
Preparation of homogenate. Heart tissue was washed thor-
oughly with ice cold saline. 10% (w/v) homogenate was prepared 
in a Potter Elvehjem type homogenizer in ice-cold 50mM phos-
phate buffer pH 7.4 containing mammalian protease inhibitor 
cocktail. The homogenate was centrifuged at 10,000xg for 30 
min at 4oC. The supernatant was used for the assay of antioxi-
dant activities/levels and lipid peroxidation.
Estimation  of  lipid  peroxidation.  Lipid  peroxidation  was 
estimated in terms of MDA formed, according to the method of 
Ohkawa, et al.40 using thiobarbituric acid (TBA) reagent. To 0.2 
ml of the homogenate, added 0.2 ml sodium dodecyl sulphate 
[8.1% (w/v)], 1.5 ml glacial acetic acid and thiobarbituric acid 
[0.8% (w/v)]. The final volume was made to 3.0 ml. The con-
tents of the tubes were vortexed vigorously, heated in a water bath 
at 90°C for 1 hr and then immediately cooled under running tap 
water. To each tube, 1.0 ml of water and 5.0 ml of a mixture of 
n-butanol and pyridine (15:1, v/v) were added and the tubes were 
of hyperglycemia induced oxidative stress as demonstrated by 
increased lipid peroxidation and was significantly recovered in 
diabetic rats who were fed with MC and TFG extracts. These 
findings are in accordance with previous report where treatment 
of diabetic rats with MC extract was found to restore the GSH 
content in RBC.31
Reduced Activities of SOD and CAT in heart tissue of diabetic 
rats have been observed in our study. The decrease in activities of 
SOD and CAT in diabetic rats may be due to increased produc-
tion of reactive oxygen radicals that can themselves reduce the 
activity of these enzymes.34 SOD is an important defense enzyme 
which converts superoxide to H2O2.35 CAT is hemeprotein, which 
decomposes H2O2 and protects the tissues from highly reactive 
OH˙–.36 The reduction of these enzymes in heart tissue may lead 
to number of deleterious effects. Administration of MC and TFG 
restores the activities of these enzymes and may help to avoid the 
deleterious effects of free radicals generated during diabetes.
In conclusion, the present study demonstrates that Momordica 
charantia and Trigonella foenum graecum exhibit antiperoxidative 
and antioxidant activities in heart tissue of alloxan induced dia-
betic rats by decreasing the levels of lipid peroxidation products 
and increasing the levels/activities of antioxidants. Thus, the role 
of these plant extracts in management of diabetes of paramount 
importance as these plant extracts may serve various purposes 
in diabetics- lower of blood glucose levels, delay complications 
(atherosclerosis, nephropathy, neuropathy and gastroparesis etc). 
Their anti-infective properties may be an added benefit as dia-
betic are known to be more susceptible to infections. Further 
investigations are necessary to find out the active components 
(s) present in these plant extracts and their mechanism of action 
and to establish their therapeutic potential in the treatment of 
diabetes and related complications.
Methods
Plant material. MC fruits and TFG seeds were purchased from 
a local vegetable market in Lucknow. Seeds were clean, dry and 
finally powdered. 
Preparation of extracts. Aqueous extract of MC. Fresh fruits 
(250 g) were taken and the seeds were removed. The fleshy parts 
were cut into small pieces and macerated with 250 ml TDW using 
electrical blander. This suspension was squeezed through a sterile 
muslin cloth, and the liquid was centrifuged at 5000 rpm for 30 
minutes in the cold. The supernatant was lyophilized at low tem-
perature and reduced pressure by the method of Karunanayaka 
et al.37 using Christ alpha 1-4, Germany.
Aqueous extract of TFG seed powder.  250g of powdered 
TFG seeds were boiled in 2500 ml distilled water for 30 mins. 
Then, the decoction was cooled for 30 mins at room tempera-
ture. Next, the cooled decoction was filtered through a coarse 
sieve twice. Finally, the filtrate was concentrated by rotavapour 
(Buchi, R-210, Germany) at 50°C to a thick paste.38
Animals and treatments. Animals. Male albino wistar rats 
weighing  150  to  200g  were  purchased  from  Central  Drug 
Research  Institute  (CDRI),  Lucknow,  India,  for  study  and 
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vortexed and centrifuged at 800xg for 20 min. The upper layer 
was aspirated out to measure the color intensity at 532 nm. The 
reference used was 1, 1, 3, 3 tetraethoxypropane (TEP).
Catalase assay. The activity of catalase was determined by 
the method of Sinha (1971).41 Catalase was assayed colorimetri-
cally at 570 nm. The reaction mixture in a total volume 1.6 ml 
contains 1.0 ml of 0.01 M, phosphate buffer, pH 7.0, 0.1 ml of 
tissue homogenate-supernatant and 0.5 ml of 2.0 M H2O2. The 
reaction was stopped by the addition of 2.0 ml dichromate acetic 
acid reagent (5% potassium dichromate and glacial acetic acid 
mixed in a 1:3 ratio). The activity was expressed as µmoles H2O2 
decomposed/min/mg protein.
SOD assay. Superoxide dismutase (SOD) activity was assayed 
by the method of Misra and Fridovich, 1972.42 3.0 ml reaction 
mixture contains of 1.5 ml of 0.1 M carbonate-bicarbonate buf-
fer, pH 10.3; 0.1 ml of 30 mM EDTA, suitable aliquot of enzyme 
preparation and water to make up the volume to 2.94 ml. The 
reaction was started by addition of 0.06 ml of 15 mM epineph-
rine. Change in absorbance was recorded at 480 nm for one min 
at 15 sec interval. Control consisting of all the ingredients, except 
enzyme preparation, was run simultaneously. One unit of enzyme 
activity has been defined to cause 50% inhibition of auto-oxida-
tion of epinephrine by 1.0 ml of homogenate.
GST activity. GST was determined using 1-chloro-2, 4-dini-
trobenzene (CDNB) as a substrate. The assay mixture contained 
1mM GSH, 1mM CDNB and 100 mM phosphate buffer, pH 
6.5. The reaction was started by the addition of enzyme in linear-
ity range, the rate of increase in absorbance due to formation of 
CDNB conjugate of GSH was monitored at 340 nm for 3 mins.   
The activity of GST is expressed as µmoles of GSH-CDNB con-
jugate formed/min/mg protein (Habig et al. 1974).43
GSH contents. 0.2 ml homogenate were mix in 0.3 ml pre-
cipitating  regent  (0.2  M  glacial  meta-phosphoric  acid,  5.1  M 
NaCl and 5.9 mM EDTA). After centrifugation at 10,000xg for   
15  minutes,  0.2  ml  supernatant  was  added  to  0.8  ml  0.3  M 
Na2HPO4,  followed  by  the  addition  of  0.1  ml  5,5  dithiobis   
(2- nitrobenzoic acid); DTNB; 0.04% in 1% sodium citrate). 
The change in optical density at 412 nm was recorded using 
UV-Vis spectrophotometer. (Chandra et al. 2002).44
Protein  estimation.  Protein  was  estimated  by  the  method 
of  Lowry  et  al.45  using  bovine  serum  albumin  as  standard,   
at 660 nm.
Statistical analysis. The results are expressed as mean ± SD 
in each group (n=5). Comparisons were made by means of one 
way analysis of variance (ANOVA) test. A values of p<0.05 were 
considered as significant.
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